{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T22:51:52Z","timestamp":1775170312809,"version":"3.50.1"},"reference-count":99,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T00:00:00Z","timestamp":1641772800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB1181 project B03"],"award-info":[{"award-number":["SFB1181 project B03"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["GRK 2599 project P3"],"award-info":[{"award-number":["GRK 2599 project P3"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["STE 432\/11-1"],"award-info":[{"award-number":["STE 432\/11-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["STE 432\/15-1"],"award-info":[{"award-number":["STE 432\/15-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["ZI 1225\/1-1"],"award-info":[{"award-number":["ZI 1225\/1-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["ZI 1225\/2-1"],"award-info":[{"award-number":["ZI 1225\/2-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["GRK 2504, project B1"],"award-info":[{"award-number":["GRK 2504, project B1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"name":"IZKF from the Universit\u00e4tsklinikum Erlangen","award":["Grant A89"],"award-info":[{"award-number":["Grant A89"]}]},{"DOI":"10.13039\/501100003042","name":"Else Kr\u00f6ner-Fresenius-Stiftung","doi-asserted-by":"publisher","award":["2020_EKEA.81"],"award-info":[{"award-number":["2020_EKEA.81"]}],"id":[{"id":"10.13039\/501100003042","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Bavarian Equal Opportunities Sponsorship \u2013 Realisierung von Chancengleichheit von Frauen in Forschung und Lehre (FFL) \u2013 Realization Equal Opportunities for Women in Research and Teaching","award":["Bavarian Equal Opportunities Sponsorship \u2013 Realisierung von Chancengleichheit von Frauen in Forschung und Lehre (FFL) \u2013 Realization Equal Opportunities for Women in Research and Teaching"],"award-info":[{"award-number":["Bavarian Equal Opportunities Sponsorship \u2013 Realisierung von Chancengleichheit von Frauen in Forschung und Lehre (FFL) \u2013 Realization Equal Opportunities for Women in Research and Teaching"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Chronic inflammatory diseases and transplant rejection represent major challenges for modern health care. Thus, identification of immune checkpoints that contribute to resolution of inflammation is key to developing novel therapeutic agents for those conditions. In recent years, the CD83 (cluster of differentiation 83) protein has emerged as an interesting potential candidate for such a \u201cpro-resolution\u201d therapy. This molecule occurs in a membrane-bound and a soluble isoform (mCD83 and sCD83, respectively), both of which are involved in resolution of inflammation. Originally described as a maturation marker on dendritic cells (DCs), mCD83 is also expressed by activated B and T cells as well as regulatory T cells (Tregs) and controls turnover of MHC II molecules in the thymus, and thereby positive selection of CD4+ T cells. Additionally, it serves to confine overshooting (auto-)immune responses. Consequently, animals with a conditional deletion of CD83 in DCs or regulatory T cells suffer from impaired resolution of inflammation. Pro-resolving effects of sCD83 became evident in pre-clinical autoimmune and transplantation models, where application of sCD83 reduced disease symptoms and enhanced allograft survival, respectively. Here, we summarize recent advances regarding CD83-mediated resolution of inflammatory responses, its binding partners as well as induced signaling pathways, and emphasize its therapeutic potential for future clinical trials.<\/jats:p>","DOI":"10.3390\/ijms23020732","type":"journal-article","created":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T17:42:25Z","timestamp":1641836545000},"page":"732","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Tilting the Balance: Therapeutic Prospects of CD83 as a Checkpoint Molecule Controlling Resolution of Inflammation"],"prefix":"10.3390","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8258-0691","authenticated-orcid":false,"given":"Katrin","family":"Peckert-Maier","sequence":"first","affiliation":[{"name":"Department of Immune Modulation, Universit\u00e4tsklinikum Erlangen, Friedrich-Alexander Universit\u00e4t\u2014Erlangen-N\u00fcrnberg, 91052 Erlangen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dmytro","family":"Royzman","sequence":"additional","affiliation":[{"name":"Department of Immune Modulation, Universit\u00e4tsklinikum Erlangen, Friedrich-Alexander Universit\u00e4t\u2014Erlangen-N\u00fcrnberg, 91052 Erlangen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pia","family":"Langguth","sequence":"additional","affiliation":[{"name":"Department of Immune Modulation, Universit\u00e4tsklinikum Erlangen, Friedrich-Alexander Universit\u00e4t\u2014Erlangen-N\u00fcrnberg, 91052 Erlangen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita","family":"Marosan","sequence":"additional","affiliation":[{"name":"Department of Immune Modulation, Universit\u00e4tsklinikum Erlangen, Friedrich-Alexander Universit\u00e4t\u2014Erlangen-N\u00fcrnberg, 91052 Erlangen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Astrid","family":"Strack","sequence":"additional","affiliation":[{"name":"Department of Immune Modulation, Universit\u00e4tsklinikum Erlangen, Friedrich-Alexander Universit\u00e4t\u2014Erlangen-N\u00fcrnberg, 91052 Erlangen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atefeh","family":"Sadeghi Shermeh","sequence":"additional","affiliation":[{"name":"Department of Immune Modulation, Universit\u00e4tsklinikum Erlangen, Friedrich-Alexander Universit\u00e4t\u2014Erlangen-N\u00fcrnberg, 91052 Erlangen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Steinkasserer","sequence":"additional","affiliation":[{"name":"Department of Immune Modulation, Universit\u00e4tsklinikum Erlangen, Friedrich-Alexander Universit\u00e4t\u2014Erlangen-N\u00fcrnberg, 91052 Erlangen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth","family":"Zinser","sequence":"additional","affiliation":[{"name":"Department of Immune Modulation, Universit\u00e4tsklinikum Erlangen, Friedrich-Alexander Universit\u00e4t\u2014Erlangen-N\u00fcrnberg, 91052 Erlangen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas B.","family":"Wild","sequence":"additional","affiliation":[{"name":"Department of Immune Modulation, Universit\u00e4tsklinikum Erlangen, Friedrich-Alexander Universit\u00e4t\u2014Erlangen-N\u00fcrnberg, 91052 Erlangen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,1,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/emmm.201202382","article-title":"Resolution of inflammation: An integrated view","volume":"5","author":"Perretti","year":"2013","journal-title":"EMBO Mol. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.cell.2019.02.028","article-title":"Resident Macrophages Cloak Tissue Microlesions to Prevent Neutrophil-Driven Inflammatory Damage","volume":"177","author":"Uderhardt","year":"2019","journal-title":"Cell"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.smim.2016.03.007","article-title":"The role of neutrophils in inflammation resolution","volume":"28","author":"Jones","year":"2016","journal-title":"Semin. Immunol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41565-020-00810-2","article-title":"Inducing immune tolerance with dendritic cell-targeting nanomedicines","volume":"16","author":"Desai","year":"2021","journal-title":"Nat. Nanotechnol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/ni.3790","article-title":"A guiding map for inflammation","volume":"18","author":"Netea","year":"2017","journal-title":"Nat. Immunol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1038\/s41467-018-05800-6","article-title":"Resolution of chronic inflammatory disease: Universal and tissue-specific concepts","volume":"9","author":"Schett","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1172\/JCI124615","article-title":"The role of macrophages in the resolution of inflammation","volume":"129","author":"Watanabe","year":"2019","journal-title":"J. Clin. Investig."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"C510","DOI":"10.1152\/ajpcell.00181.2020","article-title":"Neutrophil heterogeneity and fate in inflaMed. tissues: Implications for the resolution of inflammation","volume":"319","author":"Filep","year":"2020","journal-title":"Am. J. Physiol Cell Physiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/s41419-018-0710-y","article-title":"Neutrophils induce macrophage anti-inflammatory reprogramming by suppressing NF-kappaB activation","volume":"9","author":"Marwick","year":"2018","journal-title":"Cell Death Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/s41467-020-20540-2","article-title":"Co-stimulation with opposing macrophage polarization cues leads to orthogonal secretion programs in individual cells","volume":"12","author":"Kelsey","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/intimm\/dxy054","article-title":"Macrophages in inflammation, repair and regeneration","volume":"30","author":"Oishi","year":"2018","journal-title":"Int. Immunol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3389\/fimmu.2016.00160","article-title":"Resolution of Inflammation: What Controls Its Onset?","volume":"7","author":"Sugimoto","year":"2016","journal-title":"Front. Immunol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.it.2019.01.007","article-title":"Mediators of the Resolution of the Inflammatory Response","volume":"40","author":"Sugimoto","year":"2019","journal-title":"Trends Immunol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s00281-019-00765-0","article-title":"Resolution of inflammation during multiple sclerosis","volume":"41","author":"Ruiz","year":"2019","journal-title":"Semin. Immunopathol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s00281-019-00768-x","article-title":"Resolution of inflammation in arthritis","volume":"41","author":"Schett","year":"2019","journal-title":"Semin. Immunopathol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/imr.12146","article-title":"Inflammatory triggers of acute rejection of organ allografts","volume":"258","author":"Mori","year":"2014","journal-title":"Immunol. Rev."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nrd.2016.39","article-title":"Resolution of inflammation: A new therapeutic frontier","volume":"15","author":"Fullerton","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"735","DOI":"10.4049\/jimmunol.149.2.735","article-title":"A Novel Cell-Surface Molecule Expressed by Human Interdigitating Reticulum Cells, Langerhans Cells, and Activated Lymphocytes Is a New Member of the Ig Superfamily","volume":"149","author":"Zhou","year":"1992","journal-title":"J. Immunol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"721","DOI":"10.3389\/fimmu.2020.00721","article-title":"The CD83 Molecule\u2014An Important Immune Checkpoint","volume":"11","author":"Grosche","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.3389\/fimmu.2019.01312","article-title":"CD83: Activation Marker for Antigen Presenting Cells and Its Therapeutic Potential","volume":"10","author":"Li","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"D204","DOI":"10.1093\/nar\/gku989","article-title":"UniProt: A hub for protein information","volume":"43","author":"UniProt","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0014-5793(99)01465-9","article-title":"Cloning, recombinant expression and biochemical characterization of the murine CD83 molecule which is specifically upregulated during dendritic cell maturation","volume":"461","author":"Berchtold","year":"1999","journal-title":"FEBS Lett."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1093\/intimm\/13.7.959","article-title":"A soluble form of CD83 is released from activated dendritic cells and B lymphocytes, and is detectable in normal human sera","volume":"13","author":"Hock","year":"2001","journal-title":"Int. Immunol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"6672","DOI":"10.4049\/jimmunol.174.11.6672","article-title":"Alternative splicing generates putative soluble CD83 proteins that inhibit T cell proliferation","volume":"174","author":"Dudziak","year":"2005","journal-title":"J. Immunol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0145-2126(03)00255-8","article-title":"The soluble form of CD83 is present at elevated levels in a number of hematological malignancies","volume":"28","author":"Hock","year":"2004","journal-title":"Leukemia Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jneuroim.2018.04.005","article-title":"The levels of soluble forms of CD21 and CD83 in multiple sclerosis","volume":"320","author":"Karampoor","year":"2018","journal-title":"J. NeuroImmunol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1399-0039.2005.00524.x","article-title":"Levels of the soluble forms of CD80, CD86, and CD83 are elevated in the synovial fluid of rheumatoid arthritis patients","volume":"67","author":"Hock","year":"2006","journal-title":"Tissue Antigens"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S1471-4906(02)02214-7","article-title":"CD83 on dendritic cells: More than just a marker for maturation","volume":"23","author":"Lechmann","year":"2002","journal-title":"Trends Immunol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/mi.2014.79","article-title":"Dendritic cell CD83 homotypic interactions regulate inflammation and promote mucosal homeostasis","volume":"8","author":"Bates","year":"2015","journal-title":"Mucosal. Immunol."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Wild, A.B., Krzyzak, L., Peckert, K., Stich, L., Kuhnt, C., Butterhof, A., Seitz, C., Mattner, J., Gruner, N., and Gansbauer, M. (2019). CD83 orchestrates immunity toward self and non-self in dendritic cells. JCI Insight, 4.","DOI":"10.1172\/jci.insight.126246"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1084\/jem.20092203","article-title":"CD83 increases MHC II and CD86 on dendritic cells by opposing IL-10-driven MARCH1-mediated ubiquitination and degradation","volume":"208","author":"Tze","year":"2011","journal-title":"J. Exp. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"3958","DOI":"10.1182\/blood.V96.12.3958","article-title":"Expression of CCR6 and CD83 by cytokine-activated human neutrophils","volume":"96","author":"Yamashiro","year":"2000","journal-title":"Blood"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1042\/BJ20040741","article-title":"CD83 is preforMed. inside monocytes, macrophages and dendritic cells, but it is only stably expressed on activated dendritic cells","volume":"385","author":"Cao","year":"2005","journal-title":"Biochem. J."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1093\/intimm\/12.9.1347","article-title":"Activation-induced expression of murine CD83 on T cells and identification of a specific CD83 ligand on murine B cells","volume":"12","author":"Cramer","year":"2000","journal-title":"Int. Immunol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1084\/jem.20050128","article-title":"IL-18-induced CD83+CCR7+ NK helper cells","volume":"202","author":"Mailliard","year":"2005","journal-title":"J. Exp. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e99712","DOI":"10.1172\/jci.insight.99712","article-title":"CD83 expression is essential for Treg cell differentiation and stability","volume":"3","author":"Doebbeler","year":"2018","journal-title":"JCI Insight"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1084\/jem.20160316","article-title":"Thymic CD4 T cell selection requires attenuation of March8-mediated MHCII turnover in cortical epithelial cells through CD83","volume":"213","author":"Petrozziello","year":"2016","journal-title":"J. Exp. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1159\/000515332","article-title":"Intestinal Epithelial Cell-Derived CD83 Contributes to Regulatory T-Cell Generation and Inhibition of Food Allergy","volume":"13","author":"Yu","year":"2021","journal-title":"J. Innate Immun."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/imm.13317","article-title":"Epithelial cell-derived CD83 restores immune tolerance in the airway mucosa by inducing regulatory T-cell differentiation","volume":"163","author":"Mo","year":"2021","journal-title":"Immunology"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1099\/vir.0.062810-0","article-title":"Herpes simplex virus type 1 ICP0 induces CD83 degradation in mature dendritic cells independent of its E3 ubiquitin ligase function","volume":"95","author":"Heilingloh","year":"2014","journal-title":"J. Gen. Virol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3389\/fmicb.2017.00119","article-title":"The Major Immediate-Early Protein IE2 of Human Cytomegalovirus Is Sufficient to Induce Proteasomal Degradation of CD83 on Mature Dendritic Cells","volume":"8","author":"Heilingloh","year":"2017","journal-title":"Front. Microbiol."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Grosche, L., Muhl-Zurbes, P., Ciblis, B., Krawczyk, A., Kuhnt, C., Kamm, L., Steinkasserer, A., and Heilingloh, C.S. (2020). Herpes Simplex Virus Type-2 Paralyzes the Function of Monocyte-Derived Dendritic Cells. Viruses, 12.","DOI":"10.3390\/v12010112"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"655","DOI":"10.3324\/haematol.2017.178384","article-title":"CD83 is a new potential biomarker and therapeutic target for Hodgkin lymphoma","volume":"103","author":"Li","year":"2018","journal-title":"Haematologica"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0092-8674(02)00673-6","article-title":"CD83 expression influences CD4+ T cell development in the thymus","volume":"108","author":"Fujimoto","year":"2002","journal-title":"Cell"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1084\/jem.20030973","article-title":"Prevention and treatment of experimental autoimmune encephalomyelitis by soluble CD83","volume":"200","author":"Zinser","year":"2004","journal-title":"J. Exp. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/j.imbio.2013.06.002","article-title":"Soluble human CD83 ameliorates lupus in NZB\/W F1 mice","volume":"218","author":"Starke","year":"2013","journal-title":"Immunobiology"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1038\/mi.2013.119","article-title":"Soluble CD83 ameliorates experimental colitis in mice","volume":"7","author":"Eckhardt","year":"2014","journal-title":"Mucosal. Immunol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"12895","DOI":"10.1038\/s41598-017-13412-1","article-title":"NK cells are negatively regulated by sCD83 in experimental autoimmune uveitis","volume":"7","author":"Lin","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.3389\/fimmu.2018.01567","article-title":"Soluble CD83 Alleviates Experimental Autoimmune Uveitis by Inhibiting Filamentous Actin-Dependent Calcium Release in Dendritic Cells","volume":"9","author":"Lin","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/s41584-019-0224-8","article-title":"Soluble CD83: A proresolving mediator in inflammatory arthritis?","volume":"15","author":"McHugh","year":"2019","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"633","DOI":"10.3389\/fimmu.2019.00633","article-title":"Soluble CD83 Triggers Resolution of Arthritis and Sustained Inflammation Control in IDO Dependent Manner","volume":"10","author":"Royzman","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.imlet.2008.07.004","article-title":"CD83 on murine APC does not function as a costimulatory receptor for T cells","volume":"120","author":"Kretschmer","year":"2008","journal-title":"Immunol. Lett."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1093\/intimm\/dxm067","article-title":"CD83 influences cell-surface MHC class II expression on B cells and other antigen-presenting cells","volume":"19","author":"Kuwano","year":"2007","journal-title":"Int. Immunol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"3581","DOI":"10.4049\/jimmunol.1502163","article-title":"CD83 Modulates B Cell Activation and Germinal Center Responses","volume":"196","author":"Krzyzak","year":"2016","journal-title":"J. Immunol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.4049\/jimmunol.173.5.2995","article-title":"A novel mutation in CD83 results in the development of a unique population of CD4+ T cells","volume":"173","author":"Appleby","year":"2004","journal-title":"J. Immunol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.3389\/fimmu.2019.01751","article-title":"The Membrane-Associated MARCH E3 Ligase Family: Emerging Roles in Immune Regulation","volume":"10","author":"Lin","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1084\/jem.20160312","article-title":"Ubiquitin ligase MARCH 8 cooperates with CD83 to control surface MHC II expression in thymic epithelium and CD4 T cell selection","volume":"213","author":"Liu","year":"2016","journal-title":"J. Exp. Med."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/intimm\/dxt066","article-title":"Loss of MHC II ubiquitination inhibits the activation and differentiation of CD4 T cells","volume":"26","author":"Ishikawa","year":"2014","journal-title":"Int. Immunol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1083\/jcb.201611141","article-title":"MARCH1 protects the lipid raft and tetraspanin web from MHCII proteotoxicity in dendritic cells","volume":"217","author":"Oh","year":"2018","journal-title":"J. Cell Biol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00251-018-1094-y","article-title":"MHC class II fine tuning by ubiquitination: Lesson from MARCHs","volume":"71","author":"Ishido","year":"2019","journal-title":"Immunogenetics"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Batool, A., Liu, H., Liu, Y.X., and Chen, S.R. (2020). CD83, a Novel MAPK Signaling Pathway Interactor, Determines Ovarian Cancer Cell Fate. Cancers, 12.","DOI":"10.3390\/cancers12082269"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.leukres.2009.01.001","article-title":"Release and clinical significance of soluble CD83 in chronic lymphocytic leukemia","volume":"33","author":"Hock","year":"2009","journal-title":"Leuk. Res."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1084\/jem.194.12.1813","article-title":"The extracellular domain of CD83 inhibits dendritic cell-mediated T cell stimulation and binds to a ligand on dendritic cells","volume":"194","author":"Lechmann","year":"2001","journal-title":"J. Exp. Med."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.4049\/jimmunol.1201531","article-title":"Topical application of soluble CD83 induces IDO-mediated immune modulation, increases Foxp3+ T cells, and prolongs allogeneic corneal graft survival","volume":"191","author":"Bock","year":"2013","journal-title":"J. Immunol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1097\/TP.0b013e3181f95718","article-title":"Immunosuppression Involving Soluble CD83 Induces Tolerogenic Dendritic Cells That Prevent Cardiac Allograft Rejection","volume":"90","author":"Ge","year":"2010","journal-title":"Transplantation"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1097\/TP.0b013e3182007bbf","article-title":"Induction of kidney allograft tolerance by soluble CD83 associated with prevalence of tolerogenic dendritic cells and indoleamine 2,3-dioxygenase","volume":"90","author":"Lan","year":"2010","journal-title":"Transplantation"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1097\/TP.0b013e318200005c","article-title":"Prevention of chronic renal allograft rejection by soluble CD83","volume":"90","author":"Lan","year":"2010","journal-title":"Transplantation"},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Peckert-Maier, K., Schonberg, A., Wild, A.B., Royzman, D., Braun, G., Stich, L., Hadrian, K., Tripal, P., Cursiefen, C., and Steinkasserer, A. (2021). Pre-incubation of corneal donor tissue with sCD83 improves graft survival via the induction of alternatively activated macrophages and tolerogenic dendritic cells. Am. J. Transplant.","DOI":"10.1111\/ajt.16824"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"101351","DOI":"10.1016\/j.trim.2020.101351","article-title":"Soluble CD83 inhibits acute rejection by up regulating TGF-beta and IDO secretion in rat liver transplantation","volume":"64","author":"Xiong","year":"2021","journal-title":"Transpl Immunol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.4049\/jimmunol.1600802","article-title":"Soluble CD83 Inhibits T Cell Activation by Binding to the TLR4\/MD-2 Complex on CD14(+) Monocytes","volume":"198","author":"Horvatinovich","year":"2017","journal-title":"J. Immunol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1084\/jem.189.11.1777","article-title":"MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4","volume":"189","author":"Shimazu","year":"1999","journal-title":"J. Exp. Med."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"24914","DOI":"10.1074\/jbc.M109.000059","article-title":"Kruppel-like factor KLF10 targets transforming growth factor-beta1 to regulate CD4(+)CD25(-) T cells and T regulatory cells","volume":"284","author":"Cao","year":"2009","journal-title":"J. Biol. Chem."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"834","DOI":"10.2119\/molmed.2012.00029","article-title":"Different partners, opposite outcomes: A new perspective of the immunobiology of indoleamine 2,3-dioxygenase","volume":"18","author":"Orabona","year":"2012","journal-title":"Mol. Med."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/ni.2088","article-title":"IDO: More than an enzyme","volume":"12","author":"Chen","year":"2011","journal-title":"Nat. Immunol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"18778","DOI":"10.1073\/pnas.1018994108","article-title":"CD83-stimulated monocytes suppress T-cell immune responses through production of prostaglandin E2","volume":"108","author":"Chen","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.imbio.2004.04.003","article-title":"The soluble form of CD83 dramatically changes the cytoskeleton of dendritic cells","volume":"209","author":"Kotzor","year":"2004","journal-title":"Immunobiology"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"605713","DOI":"10.3389\/fcell.2020.605713","article-title":"Soluble CD83 Regulates Dendritic Cell-T Cell Immunological Synapse Formation by Disrupting Rab1a-Mediated F-Actin Rearrangement","volume":"8","author":"Lin","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"4613","DOI":"10.4049\/jimmunol.1600339","article-title":"The Analysis of CD83 Expression on Human Immune Cells Identifies a Unique CD83+-Activated T Cell Population","volume":"197","author":"Ju","year":"2016","journal-title":"J. Immunol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"4550","DOI":"10.4049\/jimmunol.179.7.4550","article-title":"CD83 expression is a sensitive marker of activation required for B cell and CD4+ T cell longevity in vivo","volume":"179","author":"Prazma","year":"2007","journal-title":"J. Immunol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.imbio.2014.08.005","article-title":"Murine CD83-positive T cells mediate suppressor functions in vitro and in vivo","volume":"220","author":"Kreiser","year":"2015","journal-title":"Immunobiology"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.3892\/mmr.2015.3796","article-title":"Continuous expression of CD83 on activated human CD4(+) T cells is correlated with their differentiation into induced regulatory T cells","volume":"12","author":"Chen","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"5890","DOI":"10.4049\/jimmunol.180.9.5890","article-title":"CD83 expression in CD4+ T cells modulates inflammation and autoimmunity","volume":"180","author":"Reinwald","year":"2008","journal-title":"J. Immunol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.3389\/fimmu.2019.01442","article-title":"Endogenous Expression of the Human CD83 Attenuates EAE Symptoms in Humanized Transgenic Mice and Increases the Activity of Regulatory T Cells","volume":"10","author":"Zinser","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.4049\/jimmunol.2000042","article-title":"Endogenous CD83 Expression in CD4(+) Conventional T Cells Controls Inflammatory Immune Responses","volume":"204","author":"Liedtke","year":"2020","journal-title":"J. Immunol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.3389\/fimmu.2018.01363","article-title":"An Expanded Neuroimmunomodulation Axis: sCD83-Indoleamine 2,3-Dioxygenase-Kynurenine Pathway and Updates of Kynurenine Pathway in Neurologic Diseases","volume":"9","author":"Bo","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"656452","DOI":"10.3389\/fimmu.2021.656452","article-title":"Targeting Immune Cell Trafficking\u2014Insights From Research Models and Implications for Future IBD Therapy","volume":"12","author":"Wiendl","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nrgastro.2016.208","article-title":"Current and emerging therapeutic targets for IBD","volume":"14","author":"Neurath","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1136\/gut.2009.185108","article-title":"Gut CD103+ dendritic cells express indoleamine 2,3-dioxygenase which influences T regulatory\/T effector cell balance and oral tolerance induction","volume":"59","author":"Matteoli","year":"2010","journal-title":"Gut"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/MOG.0b013e32835c9cb3","article-title":"Indoleamine 2,3 dioxygenase in intestinal disease","volume":"29","author":"Ciorba","year":"2013","journal-title":"Curr. Opin. Gastroenterol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1002\/ptr.6866","article-title":"The role of medicinal products in the treatment of inflammatory bowel diseases (IBD) through inhibition of TLR4\/NF-kappaB pathway","volume":"35","author":"Dejban","year":"2021","journal-title":"Phytother. Res."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis","volume":"365","author":"McInnes","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"235ra260","DOI":"10.1126\/scitranslmed.3007764","article-title":"T cell costimulation molecules CD80\/86 inhibit osteoclast differentiation by inducing the IDO\/tryptophan pathway","volume":"6","author":"Bozec","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13075-020-2137-y","article-title":"Identification of molecules associated with response to abatacept in patients with rheumatoid arthritis","volume":"22","author":"Yamazaki","year":"2020","journal-title":"Arthritis Res. Ther."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/cmi.2016.39","article-title":"Immunosuppression for in vivo research: State-of-the-art protocols and experimental approaches","volume":"14","author":"Diehl","year":"2017","journal-title":"Cell Mol. Immunol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/S0140-6736(20)30167-7","article-title":"Regulatory cell therapy in kidney transplantation (The ONE Study): A harmonised design and analysis of seven non-randomised, single-arm, phase 1\/2A trials","volume":"395","author":"Sawitzki","year":"2020","journal-title":"Lancet"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1432-2277.2006.00426.x","article-title":"A limited course of soluble CD83 delays acute cellular rejection of MHC-mismatched mouse skin allografts","volume":"20","author":"Xu","year":"2007","journal-title":"Transpl. Int."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"5763430","DOI":"10.1155\/2019\/5763430","article-title":"The Evolving Roles of Macrophages in Organ Transplantation","volume":"2019","author":"Li","year":"2019","journal-title":"J. Immunol. Res."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"19446","DOI":"10.1073\/pnas.0706832104","article-title":"CD4+CD25+Foxp3+ regulatory T cells induce alternative activation of human monocytes\/macrophages","volume":"104","author":"Tiemessen","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1084\/jem.20170277","article-title":"CCL22 controls immunity by promoting regulatory T cell communication with dendritic cells in lymph nodes","volume":"216","author":"Rapp","year":"2019","journal-title":"J. Exp. Med."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/2\/732\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T14:01:56Z","timestamp":1760364116000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/2\/732"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,10]]},"references-count":99,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,1]]}},"alternative-id":["ijms23020732"],"URL":"https:\/\/doi.org\/10.3390\/ijms23020732","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,10]]}}}